Cargando…

Inpatient Hospital Costs for COVID-19 Patients in the United States

INTRODUCTION: Reliable cost and resource use data for COVID-19 hospitalizations are crucial to better inform local healthcare resource decisions; however, available data are limited and vary significantly. METHODS: COVID-19 hospital admissions data from the Premier Healthcare Database were evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohsfeldt, Robert L., Choong, Casey Kar-Chan, Mc Collam, Patrick L., Abedtash, Hamed, Kelton, Kari A., Burge, Russel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491188/
https://www.ncbi.nlm.nih.gov/pubmed/34609704
http://dx.doi.org/10.1007/s12325-021-01887-4
_version_ 1784578693009506304
author Ohsfeldt, Robert L.
Choong, Casey Kar-Chan
Mc Collam, Patrick L.
Abedtash, Hamed
Kelton, Kari A.
Burge, Russel
author_facet Ohsfeldt, Robert L.
Choong, Casey Kar-Chan
Mc Collam, Patrick L.
Abedtash, Hamed
Kelton, Kari A.
Burge, Russel
author_sort Ohsfeldt, Robert L.
collection PubMed
description INTRODUCTION: Reliable cost and resource use data for COVID-19 hospitalizations are crucial to better inform local healthcare resource decisions; however, available data are limited and vary significantly. METHODS: COVID-19 hospital admissions data from the Premier Healthcare Database were evaluated to estimate hospital costs, length of stay (LOS), and discharge status. Adult COVID-19 patients (ICD-10-CM: U07.1) hospitalized in the US from April 1 to December 31, 2020, were identified. Analyses were stratified by patient and hospital characteristics, levels of care during hospitalization, and discharge status. Factors associated with changes in costs, LOS, and discharge status were estimated using regression analyses. Monthly trends in costs, LOS, and discharge status were examined. RESULTS: Of the 247,590 hospitalized COVID-19 patients, 49% were women, 76% were aged ≥ 50, and 36% were admitted to intensive care units (ICU). Overall median hospital LOS, cost, and cost/day were 6 days, US$11,267, and $1772, respectively; overall median ICU LOS, cost, and cost/day were 5 days, $13,443, and $2902, respectively. Patients requiring mechanical ventilation had the highest hospital and ICU median costs ($47,454 and $41,510) and LOS (16 and 11 days), respectively. Overall, 14% of patients died in hospital and 52% were discharged home. Older age, Black and Caucasian race, hypertension and obesity, treatment with extracorporeal membrane oxygenation, and discharge to long-term care facilities were major drivers of costs, LOS, and risk of death. Admissions in December had significantly lower median hospital and ICU costs and LOS compared to April. CONCLUSION: The burden from COVID-19 in terms of hospital and ICU costs and LOS has been substantial, though significant decreases in cost and LOS and increases in the share of hospital discharges to home were observed from April to December 2020. These estimates will be useful for inputs to economic models, disease burden forecasts, and local healthcare resource planning. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01887-4.
format Online
Article
Text
id pubmed-8491188
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-84911882021-10-05 Inpatient Hospital Costs for COVID-19 Patients in the United States Ohsfeldt, Robert L. Choong, Casey Kar-Chan Mc Collam, Patrick L. Abedtash, Hamed Kelton, Kari A. Burge, Russel Adv Ther Original Research INTRODUCTION: Reliable cost and resource use data for COVID-19 hospitalizations are crucial to better inform local healthcare resource decisions; however, available data are limited and vary significantly. METHODS: COVID-19 hospital admissions data from the Premier Healthcare Database were evaluated to estimate hospital costs, length of stay (LOS), and discharge status. Adult COVID-19 patients (ICD-10-CM: U07.1) hospitalized in the US from April 1 to December 31, 2020, were identified. Analyses were stratified by patient and hospital characteristics, levels of care during hospitalization, and discharge status. Factors associated with changes in costs, LOS, and discharge status were estimated using regression analyses. Monthly trends in costs, LOS, and discharge status were examined. RESULTS: Of the 247,590 hospitalized COVID-19 patients, 49% were women, 76% were aged ≥ 50, and 36% were admitted to intensive care units (ICU). Overall median hospital LOS, cost, and cost/day were 6 days, US$11,267, and $1772, respectively; overall median ICU LOS, cost, and cost/day were 5 days, $13,443, and $2902, respectively. Patients requiring mechanical ventilation had the highest hospital and ICU median costs ($47,454 and $41,510) and LOS (16 and 11 days), respectively. Overall, 14% of patients died in hospital and 52% were discharged home. Older age, Black and Caucasian race, hypertension and obesity, treatment with extracorporeal membrane oxygenation, and discharge to long-term care facilities were major drivers of costs, LOS, and risk of death. Admissions in December had significantly lower median hospital and ICU costs and LOS compared to April. CONCLUSION: The burden from COVID-19 in terms of hospital and ICU costs and LOS has been substantial, though significant decreases in cost and LOS and increases in the share of hospital discharges to home were observed from April to December 2020. These estimates will be useful for inputs to economic models, disease burden forecasts, and local healthcare resource planning. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01887-4. Springer Healthcare 2021-10-05 2021 /pmc/articles/PMC8491188/ /pubmed/34609704 http://dx.doi.org/10.1007/s12325-021-01887-4 Text en © The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Ohsfeldt, Robert L.
Choong, Casey Kar-Chan
Mc Collam, Patrick L.
Abedtash, Hamed
Kelton, Kari A.
Burge, Russel
Inpatient Hospital Costs for COVID-19 Patients in the United States
title Inpatient Hospital Costs for COVID-19 Patients in the United States
title_full Inpatient Hospital Costs for COVID-19 Patients in the United States
title_fullStr Inpatient Hospital Costs for COVID-19 Patients in the United States
title_full_unstemmed Inpatient Hospital Costs for COVID-19 Patients in the United States
title_short Inpatient Hospital Costs for COVID-19 Patients in the United States
title_sort inpatient hospital costs for covid-19 patients in the united states
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491188/
https://www.ncbi.nlm.nih.gov/pubmed/34609704
http://dx.doi.org/10.1007/s12325-021-01887-4
work_keys_str_mv AT ohsfeldtrobertl inpatienthospitalcostsforcovid19patientsintheunitedstates
AT choongcaseykarchan inpatienthospitalcostsforcovid19patientsintheunitedstates
AT mccollampatrickl inpatienthospitalcostsforcovid19patientsintheunitedstates
AT abedtashhamed inpatienthospitalcostsforcovid19patientsintheunitedstates
AT keltonkaria inpatienthospitalcostsforcovid19patientsintheunitedstates
AT burgerussel inpatienthospitalcostsforcovid19patientsintheunitedstates